<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04842773</url>
  </required_header>
  <id_info>
    <org_study_id>[20-AOI-09] MESSAGE</org_study_id>
    <nct_id>NCT04842773</nct_id>
  </id_info>
  <brief_title>Ultrasound (US) Measurement of Sarcopenia in the Elder Subject</brief_title>
  <acronym>MESSAGE</acronym>
  <official_title>MESSAge Study : Ultrasound Measurement of Sarcopenia in the Elder Subject</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sarcopenia is a generalized, progressive and multifactorial muscle impairment, causing&#xD;
      multiple pathologies and their consequences such as falls, fractures, dependence, worsening&#xD;
      of cognitive disorders and death. Interventions to combat the progression of sarcopenia&#xD;
      should be introduced as soon as clinically suspected, based on functional tests to measure&#xD;
      muscle strength. Diagnostic confirmation of sarcopenia can be done using several validated&#xD;
      methods of estimating muscle mass: magnetic resonance imaging (MRI), computed tomography&#xD;
      (CT), biphotonic absorptiometry (DEXA) or bio-impedanceometry. Their availability in clinical&#xD;
      routine remains limited due to their high costs and/or lack of accessibility depending on the&#xD;
      place of practice. On the other hand, there are certain pitfalls for carrying out these&#xD;
      various examinations, in connection with several common clinical problems in the study&#xD;
      population: mobility disorders and neurodegenerative disorders disabling for transport and&#xD;
      access to the examination table for imaging examinations, hydration disorders distorting&#xD;
      measures for bio-impedancetry.&#xD;
&#xD;
      Previous studies suggest that ultrasound may be as effective a tool as previous methods for&#xD;
      diagnostic confirmation of sarcopenia. Because of its non-invasive and non-irradiating&#xD;
      nature, its affordability, its short duration of realization, its availability and its low&#xD;
      constraints of realization, the ultrasound could help to remove some of the current limits to&#xD;
      the diagnostic confirmation of sarcopenia.&#xD;
&#xD;
      The investigators hypothesis is that ultrasound can be used to implement a simple and&#xD;
      reliable protocol for assessing sarcopenia in the elderly. It could also be used to detect&#xD;
      sarcopenia at an early stage (&quot;presarcopenia&quot;) while the decrease in muscle mass is not yet&#xD;
      accompanied by a decrease in skeletal muscle strength.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 27, 2021</start_date>
  <completion_date type="Anticipated">May 27, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 27, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Combinaison of US measurements</measure>
    <time_frame>1 day</time_frame>
    <description>To determine the most relevant combination of ultrasound measurements, the investigators will assess the muscles thickness in centimeters.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inter-operator reproductibility</measure>
    <time_frame>1 day</time_frame>
    <description>To assess inter-operator reproducibility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle elasticity</measure>
    <time_frame>1 day</time_frame>
    <description>To explore whether muscle elasticity is a relevant ultrasound measure for assessing sarcopenia in an elderly geriatric population. Muscles elasticity will be assessed in meter/seconde.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>US measurement of sarcopenia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasound measurement</intervention_name>
    <description>Ultrasound measurement of sarcopenia in an elderly population</description>
    <arm_group_label>US measurement of sarcopenia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 75 or older&#xD;
&#xD;
          -  SARC-F &gt; 4&#xD;
&#xD;
          -  Decrease in muscle strength: grip strength &lt;27 kg for men and &lt;16 kg for women; and/or&#xD;
             Chair stand test &lt; 15 seconds&#xD;
&#xD;
          -  Patient affiliated or beneficiary of a social security plan&#xD;
&#xD;
          -  Patient who has signed informed consent beforehand&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neurocognitive disorder preventing the expression of informed consent&#xD;
&#xD;
          -  Lack of a measurement site (muscle resection or amputation)&#xD;
&#xD;
          -  Impossibility or contraindication to strict dorsal and/or ventral decubitus&#xD;
&#xD;
          -  Any associated neuromuscular pathology that may alter muscle composition and&#xD;
             trophicity&#xD;
&#xD;
          -  Wearing a pacemaker&#xD;
&#xD;
          -  Any state of water inflation or dehydration&#xD;
&#xD;
          -  History of surgery on the studied lower limb less than 6 months old&#xD;
&#xD;
          -  Patients protected by law under guardianship or under curate, or unable to participate&#xD;
             in a clinical study under Article L. 1121-16 of the French Code of Public Health&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laetitia Imbert de la Phalecque</last_name>
    <phone>0492034819</phone>
    <email>imbertdelaphalecque.l@chu-nice.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emeline I Michel, MD</last_name>
    <phone>0492034399</phone>
    <email>michel.e@chu-nice.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Nice</name>
      <address>
        <city>Nice</city>
        <zip>06001</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laetitia Imbert de la Phalecque</last_name>
      <phone>0492034819</phone>
      <email>imbertdelaphalecque.l@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Guillaume SACCO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 7, 2021</study_first_submitted>
  <study_first_submitted_qc>April 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2021</study_first_posted>
  <last_update_submitted>June 4, 2021</last_update_submitted>
  <last_update_submitted_qc>June 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

